Adults 50 to 79, any sex, with Hearing Aids or Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Profile of Hearing Aid BenefitPrimary· 6 weeks
66-item self-assessment, disability-based inventory. Participants answer the questionnaire twice, first prior to use of hearing aids and then after hearing aid use. The questionnaire is scored between 0-99% with higher values representing greater difficulty. Benefit is reported as the difference between the two scores with a higher number signifying greater benefit.
Group
Value
95% CI
Audiology-Based Best Practice
23.34
21.43 – 25.26
Consumer Decides
23.27
21.54 – 25
Efficient Fitting
23.33
21.25 – 25.12
Hearing Handicap Inventory for the ElderlySecondary· 6 weeks
A self-administered scale to identify problems related to hearing loss. The questionnaire has 25 items and can be scored between 0 and 100. The score after hearing aid use is subtracted from the baseline score (prior to hearing aid use) to obtain the benefit score. The higher the difference the greater the benefit.
Group
Value
95% CI
Audiology-Based Best Practice
20.65
18.11 – 23.19
Consumer Decides
21.83
19.42 – 24.23
Efficient Fitting
19.15
16.59 – 21.73
Duration of Hearing Aid UseSecondary· 6 weeks
Average hours of hearing aid use per day.
Group
Value
95% CI
Audiology-Based Best Practice
8.42
7.91 – 8.92
Consumer Decides
7.18
6.64 – 7.72
Efficient Fitting
6.83
6.32 – 7.34
Adverse events — posted to ClinicalTrials.gov
Time frame: 6 months.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Satisfaction and benefit from hearing aids fit using two patient self fit methods will be compared against those fit using audiology-based best practices. Individuals between the ages of 50 and 79 years of age will be randomly assigned to one of three fitting methods. Benefit and satisfaction will be evaluated six weeks and six months after the initial fitting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06117254 — Hearing Aids for Veterans With Functional Hearing Difficulties
· NA
· recruiting
NCT03345654 — Individually-guided Hearing Aid Fitting
· completed
NCT05653999 — Assessing Speech Perception and Amplification Benefit During Infancy
· completed
NCT05694039 — A Prospective Cohort Study On Change of Cognitive Function In Aged-related Hearing Loss With Hearing Aids
· NA
· recruiting
Other recruiting trials for Hearing Aids
Currently open trials in the same condition.
NCT06377215 — Understanding Aided Speech Perception in Noise
· NA
· recruiting
NCT07216937 — Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing in the Normal Range
· NA
· recruiting
NCT06689865 — Innovations in Hearing Accessibility and Technology (IHAT) Study
· NA
· recruiting
Other Northwestern University trials
Trials by the same sponsor.
NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies
· Phase 1, PHASE2
· not yet recruiting
NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C
· EARLY_PHASE1
· not yet recruiting
NCT07392775 — ALDH2 Genetic Testing in East Asian Community
· NA
· not yet recruiting
NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill
· NA
· not yet recruiting
NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwestern University
Last refreshed: 6 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04618315.